[1]
Dr.Surbhi Kansal and Mainsha Jain, “IN VITRO SUSCEPTIBILITY PROFILES OF FTOLOZANE–TAZOBACTAM AND CEFTAZIDIME–AVIBACTAM AGAINST AMPC/ ESBL PRODUCING ENTEROBACTERIACEAE”, J Popl Ther Clin Pharmacol, vol. 33, no. 2, pp. 841–852, May 2026, doi: 10.69980/1gsrfr34.